Integration of proteomic aging clocks in a phase 2a clinical trial supports simultaneous geroprotective assessment.
- DOI
- 10.1038/s41587-026-03286-y
- Published
- 2026 Sep 7
- Container
- Nature biotechnology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41587-026-03286-y,
title = {Integration of proteomic aging clocks in a phase 2a clinical trial supports simultaneous geroprotective assessment.},
author = {Zhavoronkov A and Galkin F and Chen S and Ren F and Aliper A and Durymanov M and Sidorenko D and Cui H and Han JJ and Xu H and Liu X and Xu Z and Kuppe C and Austin Argentieri M and Ying K and Goeminne LJE and Moqri M and Tyshkovskiy A and Gladyshev VN},
year = {2026},
journal = {Nature biotechnology},
doi = {10.1038/s41587-026-03286-y},
url = {https://doi.org/10.1038/s41587-026-03286-y}
}RIS
TY - JOUR TI - Integration of proteomic aging clocks in a phase 2a clinical trial supports simultaneous geroprotective assessment. AU - Zhavoronkov A AU - Galkin F AU - Chen S AU - Ren F AU - Aliper A AU - Durymanov M AU - Sidorenko D AU - Cui H AU - Han JJ AU - Xu H AU - Liu X AU - Xu Z AU - Kuppe C AU - Austin Argentieri M AU - Ying K AU - Goeminne LJE AU - Moqri M AU - Tyshkovskiy A AU - Gladyshev VN PY - 2026 JO - Nature biotechnology DO - 10.1038/s41587-026-03286-y UR - https://doi.org/10.1038/s41587-026-03286-y ER -
APA
A, Z., F, G., S, C., F, R., A, A., M, D., D, S., H, C., JJ, H., H, X., X, L., Z, X., C, K., M, A. A., K, Y., LJE, G., M, M., A, T., & VN, G. (2026). Integration of proteomic aging clocks in a phase 2a clinical trial supports simultaneous geroprotective assessment.. Nature biotechnology. https://doi.org/10.1038/s41587-026-03286-y
Source records
- pubmed · retrieved 2026-09-26T10:14:38.744Z